Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

656 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sphingomyelin as a myelin biomarker in CSF of acquired demyelinating neuropathies.
Capodivento G, Visigalli D, Garnero M, Fancellu R, Ferrara MD, Basit A, Hamid Z, Pastore VP, Garibaldi S, Armirotti A, Mancardi G, Serrati C, Capello E, Schenone A, Nobbio L. Capodivento G, et al. Among authors: basit a. Sci Rep. 2017 Aug 10;7(1):7831. doi: 10.1038/s41598-017-08314-1. Sci Rep. 2017. PMID: 28798317 Free PMC article.
Patch clamp-assisted single neuron lipidomics.
Merrill CB, Basit A, Armirotti A, Jia Y, Gall CM, Lynch G, Piomelli D. Merrill CB, et al. Among authors: basit a. Sci Rep. 2017 Jul 13;7(1):5318. doi: 10.1038/s41598-017-05607-3. Sci Rep. 2017. PMID: 28706218 Free PMC article.
Author Correction: Patch clamp-assisted single neuron lipidomics.
Merrill CB, Basit A, Armirotti A, Jia Y, Gall CM, Lynch G, Piomelli D. Merrill CB, et al. Among authors: basit a. Sci Rep. 2018 Apr 25;8(1):6772. doi: 10.1038/s41598-018-24605-7. Sci Rep. 2018. PMID: 29691427 Free PMC article.
Exploiting Sphingo- and Glycerophospholipid Impairment to Select Effective Drugs and Biomarkers for CMT1A.
Visigalli D, Capodivento G, Basit A, Fernández R, Hamid Z, Pencová B, Gemelli C, Marubbi D, Pastorino C, Luoma AM, Riekel C, Kirschner DA, Schenone A, Fernández JA, Armirotti A, Nobbio L. Visigalli D, et al. Among authors: basit a. Front Neurol. 2020 Aug 25;11:903. doi: 10.3389/fneur.2020.00903. eCollection 2020. Front Neurol. 2020. PMID: 32982928 Free PMC article.
Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease.
Di Pardo A, Amico E, Basit A, Armirotti A, Joshi P, Neely MD, Vuono R, Castaldo S, Digilio AF, Scalabrì F, Pepe G, Elifani F, Madonna M, Jeong SK, Park BM, D'Esposito M, Bowman AB, Barker RA, Maglione V. Di Pardo A, et al. Among authors: basit a. Sci Rep. 2017 Jul 13;7(1):5280. doi: 10.1038/s41598-017-05709-y. Sci Rep. 2017. PMID: 28706199 Free PMC article.
Author Correction: Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease.
Di Pardo A, Amico E, Basit A, Armirotti A, Joshi P, Neely MD, Vuono R, Castaldo S, Digilio AF, Scalabrì F, Pepe G, Elifani F, Madonna M, Jeong SK, Park BM, D'Esposito M, Bowman AB, Barker RA, Maglione V. Di Pardo A, et al. Among authors: basit a. Sci Rep. 2018 May 24;8(1):8266. doi: 10.1038/s41598-018-23083-1. Sci Rep. 2018. PMID: 29795393 Free PMC article.
656 results